PhytoHealth Corporation

Taiwan Stock Exchange 4108.TW

PhytoHealth Corporation Debt to Equity Ratio for the year ending December 31, 2023: 0.01

PhytoHealth Corporation Debt to Equity Ratio is 0.01 for the year ending December 31, 2023, a -7.79% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • PhytoHealth Corporation Debt to Equity Ratio for the year ending December 31, 2022 was 0.02, a 1.31% change year over year.
  • PhytoHealth Corporation Debt to Equity Ratio for the year ending December 31, 2021 was 0.02, a 16.00% change year over year.
  • PhytoHealth Corporation Debt to Equity Ratio for the year ending December 31, 2020 was 0.01, a 11.20% change year over year.
  • PhytoHealth Corporation Debt to Equity Ratio for the year ending December 31, 2019 was 0.01, a 3,169.81% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Taiwan Stock Exchange: 4108.TW

PhytoHealth Corporation

CEO Ms. Yi-Li Lee
IPO Date July 16, 2008
Location Taiwan
Headquarters No.167, Fu Hsing North Road
Employees 84
Sector Healthcare
Industries
Description

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Similar companies

3164.TW

GenMont Biotech Incorporation

USD 0.61

NA

4133.TW

Abnova (Taiwan) Corporation

USD 0.95

NA

4164.TW

CHC Healthcare Group

USD 1.34

NA

4106.TW

Apex Medical Corp.

USD 0.74

NA

1734.TW

Sinphar Pharmaceutical Co.,Ltd.

USD 0.94

NA

StockViz Staff

February 5, 2025

Any question? Send us an email